AESGP Annual Meeting, Day 2 (Part 2): Can Regulation Be A Catalyst For Innovation?

09 Jun 2022

Regulation should be seen as a spur to creativity rather than a burden, suggest panellists during the second session of the AESGP's 58th Annual Meeting in Madrid, Spain. Sanofi Consumer Healthcare boss Julie van Ongevalle also makes the case for electronic patient information leaflets as a way to learn from the pandemic, which she describes as the greatest constraint the world has experienced in recent history.

“What is creativity?” asked Morten Friis-Olivarius, CEO of the Copenhagen Institute of NeuroCreativity (CINC), at the beginning of the second session of the Association of the European Self-Care Industry’s 58th Annual Meeting in Madrid, Spain.

From a neuroscience point of view, creativity is about novelty and usefulness, he said. Innovations have to have some kind...